Trisomy 21: How an Extra Chromosome Disrupts the Brain's White Matter bioRxiv

Original: "Oligodendrocyte Enriched Brain Organoids Reveal Impaired Oligodendroglial Maturation and Altered Neural Network Activity in Down Syndrome"
b42w:2608.90057 · the paper's page · 2026-08-28 · CC BY 4.0 · 3 min
Brain organoids carrying an extra copy of chromosome 21 have revealed that the myelin deficit in Down syndrome is set in motion at the earliest stages of development.

Context

The work sits off to the side: the nearest neighbors in the archive study delays in biological rhythms, the retina as a window into the brain, and the mechanics of phagocytosis. Our topic is cell fate in the developing brain under chromosomal imbalance. Nearby are studies where individual cell lines or animal models give a fragmentary picture. Here, for the first time, a human three-dimensional system has been assembled in which oligodendrocytes, neurons, and astrocytes, along with their interactions, are all visible at once against the backdrop of trisomy 21.

Methods

Cerebral organoids were grown from human induced pluripotent stem cells with trisomy 21 and from an isogenic control using an accelerated protocol that yields mature myelinating oligodendrocytes in 42 days. The cells were taken through the stages of neuroectoderm and neurospheres, with a cocktail of growth factors added: PDGF-AA, HGF, IGF-1, T3, and NT-3. By day 60 the organoids contained oligodendrocytes, neurons, and astrocytes. Growth, cell lineage markers, electrical activity on multielectrode arrays, and the full transcriptome by RNA sequencing were then compared on days 35, 42, and 60.

Results

Trisomic organoids lagged in size at the early stages, but by day 42 they had almost caught up with the control. Yet the cellular composition remained defective: the number of oligodendrocyte precursors (SOX10-positive) was reduced on days 21 and 42, and the mature myelin markers PLP1 and MBP gave a significantly weaker signal by day 60. At the same time, the number of astrocytes (GFAP-positive) rose, while mature neurons (NEUN-positive) became fewer. On multielectrode arrays, trisomic networks showed spontaneous hyperactivity: the mean spike rate and burst rate were higher than in the control. However, when stimulated with 4-aminopyridine or bicuculline, the response was weakened: bursts became shorter and less frequent. Transcriptome analysis showed that the largest differences arise on day 35: 1380 genes activated and 1501 suppressed compared with the control. Among the suppressed pathways are extracellular matrix organization, Wnt and Hippo signaling, and on day 60, genes of inhibitory neurons. Immunostaining confirmed a shift toward excitatory neurons: GABA-positive cells became fewer, while CTIP2-positive cells became more numerous.

Implications

Unlike neighboring studies that examine isolated cellular processes or network behavior, this work is the first to show, in a single human model, the link between early disruption of cell specialization and late functional deficit. Trisomy 21 does not simply slow development: it redirects the fate of glial precursors, so that instead of oligodendrocytes they more often become astrocytes. This shifts the focus from 'broken myelin' to 'broken path choice' at the very beginning.

Future development

Next, the fate of individual cells can be tracked using genetic barcoding to see directly how oligodendrocyte precursors depart into the astrocytic lineage. Longer culturing will show whether the myelin deficit is irreversible or merely a delay. Adding vascular and immune components will bring the model closer to the real brain and make it possible to test the influence of inflammation.

Impact

The results will influence research on Down syndrome, the biology of myelination, and cell plasticity. The model is suitable for screening drugs aimed at restoring the balance of glial lineages.

Next steps

Verify reproducibility on additional trisomy 21 lines and isogenic controls. Perform lineage tracing and pharmacological correction to search for points of intervention.

Key open problems

The work directly addresses the unresolved question of glial precursor cell plasticity: which signals determine the choice between oligodendrocyte and astrocyte in the early human brain. It also approaches the problem of why, in Down syndrome, white matter suffers more than can be explained by developmental delay alone.

Trisomy 21 organoids spontaneously 'talk' more often than healthy ones, but when you try to make them respond to a stimulus, they fall apart, like an orchestra that makes noise without a conductor but cannot play from the score.

Key numbers

  • 42 days: the time to obtain myelinating oligodendrocytes in the accelerated protocol
  • 1380 genes: activated in trisomic organoids on day 35 compared with the control
  • 1501 genes: suppressed in trisomic organoids on day 35
  • day 60: the moment of maximum deficit in myelin markers and the shift toward excitatory neurons
  • 3%: the share of SOX10-positive cells in organoids by day 60

Take the whole work

Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.

Concepts
neurodegeneration alzheimers disease parkinsons disease epigenetic aging parietal region brain rhythmic transport